Astera Labs, Inc. (NASDAQ:ALAB – Get Free Report) Director Manuel Alba sold 63,000 shares of the stock in a transaction on Wednesday, April 2nd. The stock was sold at an average price of $63.37, for a total value of $3,992,310.00. Following the transaction, the director now owns 444,863 shares in the company, valued at $28,190,968.31. The trade was a 12.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Astera Labs Price Performance
NASDAQ:ALAB opened at $52.94 on Friday. Astera Labs, Inc. has a one year low of $36.22 and a one year high of $147.39. The company has a market cap of $8.58 billion and a PE ratio of -30.60. The firm’s 50 day simple moving average is $78.49 and its 200 day simple moving average is $90.43.
Astera Labs (NASDAQ:ALAB – Get Free Report) last issued its quarterly earnings data on Monday, February 10th. The company reported $0.10 earnings per share for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative return on equity of 10.40% and a negative net margin of 21.05%. Equities research analysts expect that Astera Labs, Inc. will post 0.34 EPS for the current year.
Hedge Funds Weigh In On Astera Labs
Wall Street Analyst Weigh In
ALAB has been the topic of a number of recent research reports. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $120.00 price target on the stock in a research report on Tuesday, January 28th. Needham & Company LLC reaffirmed a “buy” rating and issued a $140.00 price objective on shares of Astera Labs in a report on Tuesday, February 11th. Barclays upped their price target on shares of Astera Labs from $87.00 to $135.00 and gave the stock an “overweight” rating in a report on Friday, January 17th. Morgan Stanley decreased their price objective on shares of Astera Labs from $142.00 to $114.00 and set an “equal weight” rating on the stock in a research note on Tuesday, January 28th. Finally, Raymond James assumed coverage on Astera Labs in a research note on Friday, March 14th. They set an “outperform” rating and a $82.00 target price for the company. One analyst has rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, Astera Labs currently has an average rating of “Buy” and an average target price of $112.77.
View Our Latest Stock Analysis on Astera Labs
About Astera Labs
Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.
See Also
- Five stocks we like better than Astera Labs
- What Are Some of the Best Large-Cap Stocks to Buy?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- How to Use the MarketBeat Stock Screener
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Astera Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astera Labs and related companies with MarketBeat.com's FREE daily email newsletter.